Clinical Trial Update: Comparison of Insulin Tregopil (IN-105) With Insulin Aspart in Type 2 Diabetes Mellitus Patients [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial comparing Insulin Tregopil (IN-105) to Insulin Aspart in Type 2 Diabetes Mellitus has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin Tregopil (IN-105) (insulin tregopil)
• Insulin aspart (insulin aspart)

Snippet

Sponsor: Biocon Limited | Conditions: Type2 Diabetes Mellitus | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2020-05-15